Pulmonary Fibrosis: all 685 studies
Page 4 of 7. Open to participants first (120), then studies with results posted, then the rest; newest registration first within each.
- Pulmonary Fibrosis Lung Sounds StudyStatus unknownNCT05771740
- A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary FibrosisStatus unknownNCT05747508Phase 2
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy SubjectsCompletedNCT05740475Phase 1
- Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary FibrosisCompletedNCT05722964Phase 2
- Diagnostic and Prognostic Model of Pulmonary Fibrosis After COVID-19 Pneumonia and Mechanism StudyStatus unknownNCT05719038
- Oxygen Nanobubble Drink Impact on Exercise in Pulmonary FibrosisCompletedNCT05711290Not applicable
- Safety of Nintedanib in Real World in ChinaWithdrawnNCT05676112
- Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001CompletedNCT05657184Phase 1
- Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary FibrosisCompletedNCT05648734
- Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary ExacerbationsWithdrawnNCT05641298Phase 2
- Digital App for Telerehabilitation in Respiratory DiseasesStatus unknownNCT05572346
- Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary FibrosisActive, not recruitingNCT05570058Phase 2
- Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19Status unknownNCT05516550Phase 2/3
- Atezolizumab for Idiopathic Pulmonary FibrosisActive, not recruitingNCT05515627Phase 1
- To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPFCompletedNCT05483907Phase 2
- Comparison of the 1-min Sit-to-Stand Test to the 6-minute Walk Test in the Respiratory Functional Assessment of Pulmonary FibrosisStatus unknownNCT05449431Not applicable
- Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy VolunteersCompletedNCT05428150Phase 1
- A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary FibrosisStatus unknownNCT05424887Phase 2
- Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative CareCompletedNCT05407272Not applicable
- Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary FibrosisStatus unknownNCT05387785Phase 1
- Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19SuspendedNCT05387239Phase 2
- To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy VolunteersCompletedNCT05383131Phase 1
- RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)Status unknownNCT05373914Phase 2
- FAPI PET for Lung FibrosisActive, not recruitingNCT05365802Early Phase 1
- Effects of Home-based Inspiratory Muscle Training in Patients With IPFCompletedNCT05353556Not applicable
- A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary FibrosisWithdrawnNCT05349760Phase 2
- Platelets in Cystic Fibrosis Lung InflammationCompletedNCT05339724
- A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in ChinaCompletedNCT05337163
- Evaluation of the Value of 18F-Fluoromisonidazole (18F-FMISO) Positron Emission Tomography Hypoxia Imaging in Idiopathic Pulmonary FibrosisCompletedNCT05331729Phase 1
- A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye DiseaseCompletedNCT05331300Phase 1/2
- LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)Active, not recruitingNCT05321420Phase 2
- Inspiratory Effort and Respiratory Mechanics in Spontaneously Breathing Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Matched Control StudyActive, not recruitingNCT05313672
- Comparison of Pulmonary Telerehabilitation and Physical Activity Recommendations in Patients With Post Covid FibrosisCompletedNCT05299333Not applicable
- Evaluation of Postmortem Pulmonary Interstitial Fibrosis Severity and EGFR Positivity in Covid-19 PneumoniaCompletedNCT05290441Not applicable
- Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CFCompletedNCT05276960Phase 4
- Effects of Exercise Training on Respiratory Performance in Patients With Fibrosing Interstitial Lung DiseasesCompletedNCT05227443Not applicable
- Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286CompletedNCT05180162Phase 1
- Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients.Status unknownNCT05174741Not applicable
- Homecare Integral Support Program for IPF PatientsCompletedNCT05173571Not applicable
- Measurment of Interleuukin-6 at Exhaled Breath Condensate of Covid-19 Patients and Post Covid-19 Patients With Lung Fibrosis Randomized Controlled StudyStatus unknownNCT05157204
- A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy SubjectsCompletedNCT05154240Phase 1
- The Relationship Between Hormone Sensitivity and Imaging of Idiopathic Interstitial Pneumonia by Artificial IntelligenceCompletedNCT05146934
- Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy ParticipantsCompletedNCT05134727Phase 1
- Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF）CompletedNCT05119972Phase 1/2
- Sleep Disorders in Idiopathic Pulmonary FibrosisCompletedNCT05113654
- Palliative Care Planner (PCplanner)CompletedNCT05095363Not applicable
- A Study to Investigate Cystic Fibrosis Pulmonary Exacerbations and the Lung MicrobiomeTerminatedNCT05088447
- Influence of Regular Physical Activity on Sleep in Patients With COPD and Idiopathic Lung FibrosisStatus unknownNCT05087017
- 23andMe IPF Research StudyCompletedNCT05028894
- A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of PMG1015CompletedNCT05022771Phase 1
- Efficacy of Steroid Pulse Therapy in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF) Admitted in ERCompletedNCT04996303Not applicable
- Low-field Magnetic Resonance Imaging of Pediatric COVID-19Status unknownNCT04990531Not applicable
- Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental InteractionsCompletedNCT04987606
- Pulmonary Fibrosis During Severe COVID-19 PneumoniaActive, not recruitingNCT04987528
- A Trial of SHR - 1906 in Healthy SubjectsCompletedNCT04986540Phase 1
- Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University HospitalCompletedNCT04979884Phase 3
- A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT04968574Phase 2
- Post Acute Sequelae of COVID-19Active, not recruitingNCT04964115
- Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID FibrosisActive, not recruitingNCT04948203Phase 2/3
- A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy VolunteersCompletedNCT04931147Phase 1
- Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.Status unknownNCT04912011Phase 4
- To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy VolunteersCompletedNCT04888728Phase 1
- To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy VolunteersCompletedNCT04888715Phase 1
- Dyspnea and Idiopathic Pulmonary FibrosisCompletedNCT04864990
- Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 PneumoniaStatus unknownNCT04856111Phase 4
- Colchicine and Post-COVID-19 Pulmonary FibrosisActive, not recruitingNCT04818489Phase 4
- COVID-19 Pathophysiology of Long Term ImplicationsStatus unknownNCT04813575Not applicable
- The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19Status unknownNCT04805086Phase 1/2
- Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung DiseaseCompletedNCT04803617
- Outcome of Idiopathic Pulmonary Fibrosis With PregnancyCompletedNCT04775277
- To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult VolunteersCompletedNCT04767815Phase 1
- A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal SubjectsCompletedNCT04720443Phase 1
- Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory DiseasesStatus unknownNCT04693975
- Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILDActive, not recruitingNCT04680832
- 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability StudyWithdrawnNCT04677426Phase 2
- Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19CompletedNCT04645368
- Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)SuspendedNCT04643769Phase 1
- The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary FibrosisTerminatedNCT04638517Phase 2
- Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19Status unknownNCT04607928Phase 2
- Saracatinib in the Treatment of Idiopathic Pulmonary FibrosisActive, not recruitingNCT04598919Phase 1/2
- TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary FibrosisTerminatedNCT04589260Phase 1
- FIBRotic Interstitial Lung Disease and Nocturnal OXygenCompletedNCT04586946
- Reliability and Validity of iOS in IPFCompletedNCT04572971
- Changes in iOS in IPFActive, not recruitingNCT04572958
- High-flow Oxygen Therapy During Exercise in Idiopathic Pulmonary FibrosisCompletedNCT04564664Not applicable
- Advancing Prevention of Pulmonary FibrosisActive, not recruitingNCT04564183
- Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary FibrosisCompletedNCT04551781Not applicable
- Medication Adherence and Non-adherence in Adults With Rare DiseaseWithdrawnNCT04541875
- Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at DischargeStatus unknownNCT04537130Phase 1
- An Atlas of Airways at a Single Cell Level in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and ControlsCompletedNCT04529993Not applicable
- Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 PneumoniaCompletedNCT04527354Phase 2
- Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 PatientsStatus unknownNCT04517162Phase 1/2
- Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female SubjectsCompletedNCT04512170Phase 1
- Morphine for Dyspnea in Pulmonary FibrosisStatus unknownNCT04497831Phase 3
- Development of Airway Absorption Sampling MethodsWithdrawnNCT04494334
- Home Monitoring and Evaluation After Admission for COVID-19 in the NetherlandsCompletedNCT04488562
- BIO 300 Oral Suspension in Previously Hospitalized Long COVID PatientsActive, not recruitingNCT04482595Phase 2
- Inspiratory Muscle Training in Patients With Interstitial Lung DiseaseCompletedNCT04481074Not applicable
- Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary FibrosisCompletedNCT04461587Phase 2
- To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung DiseaseCompletedNCT04430491